News
Bionobis signs a new agreement with one of the world leaders specializing in the manufacture of devices to fight against Covid-19.
Bionobis signs a new agreement with one of the world leaders specializing in the manufacture of devices to fight against Covid-19.Bionobis is positioned on the PRE-ANALYTICAL and ANALYTICAL market by presenting a complete range of MDs (for oropharyngeal /...
Bionobis launches the new DigitalTRACE ™ range on the market for the study of post-graft chimerism
Description
NGS New Activity
New ActivityBionobis has recently designed and developed an innovative system for HLA genotyping by the NGS technique. Our NanoStar® system offers a fully automated workflow, HLA typing kits and dedicated analysis software.
Bionobis is ISO 13485 : 2016 certification in progress
Déscription
Contact Us
Bionobis
+33 (0)1 30 43 01 55
+33 (0)1 30 43 01 15
7, Rue Nicolas Copernic
78280 GUYANCOURT
SQY - FRANCE